Home / Uncategorized / Avastin for breast cancer gets thumbs down from FDA panel

Avastin for breast cancer gets thumbs down from FDA panel

Six-member panel of cancer experts said studies show drug to be ineffective, unsafe

Original post:
Avastin for breast cancer gets thumbs down from FDA panel

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top